Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Propofol vs Remimazolam on Mean Circulatory Filling Pressure
jRCT1011210026Not yet recruiting
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in pancreatic cancer (PC), liver cancer, bladder cancer and 2 more comparing Propofol arm with Remimazolam arm (2 arms). Primary endpoint: Change in mean circulatory filling pressure (MCFP). Planned start Jul 2021; status: not yet recruiting.
02
Drugs
propofolremimazolam
03
Conditions
pancreatic cancer (PC)liver cancerbladder cancercolon cancergastric cancer (GC)
Beyond the preview
Go deeper on jRCT1011210026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1011210026.